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Results and Conclusions
The dysbiosis found, with a marked decrease in the percentage of firmicutes
and a considerable increase in the percentage of bacterioidetes, together with a
decrease in diversity is associated with inflammatory disease (IBD) and Chron
(CD). Simultaneously, it is observed that the species B. vulgatus, B. ovatus, B.
fragilis, B. dorei, which are indicative of inflammatory disease (IBD) and
Chron (CD) and are associated with overweight and obesity, have been found
in very high proportions.
The patient is diagnosed with IBD, which is a risk factor for Chron's disease
and colorectal cancer. It is possible that it is in a previous stage to the disease,
since familiar antecedents are known, although on the other hand it is possible
to emphasize the high index of Faecalibacterium prausnitzii found, that
apparently has a protective role of the intestinal mucosa. It emphasizes the
practically absence of lactobacillus.
Among the proteobacteria there is a clear predominance of E. coli, which is
normal. In the Phylum actinobacteria, more than 50% correspond to the species
Bifidobacterium adolescentes, but a low diversity is observed.
The few human cells found indicate that there is no excessive desquamation, so
the intestinal mucosa should not be very altered.
Based on the study realized, we can conclude that the use of the XGN-MBI
assay allows to have a clear vision of the intestinal microbiota as a whole,
without incurring the error that supposes for the proportions and composition a
selection according to the culture medium and allows to observe in the same
test bacteria, fungi, viruses and parasites. Provides rapid identification of
pathogens. Depending on the number of human cells detected, it can be
inferred if there is excessive desquamation of the mucosa. The direct study of
proportions between individuals allows rapid detection of whether or not there
is dysbiosis and the enterotype of the patient.
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Introduction
The microbiota of the colon and rectum is the most abundant and diverse of the
human body, with a density of up to 1-2 kg of weight and a diversity that
exceeds a thousand species. The main bacteria of the intestinal microbiota
correspond to four phylums: Bacterioidetes, Firmicutes, Actinobacteria and
proteobacteria, with the first two accounting for 90% of all intestinal bacteria.
The microbiota is considered, today, as a new organ due to the important
functions it performs and which are fundamental for health.
Metagenomics can be defined as the application of modern genomic
techniques for the direct study of communities of microorganisms in their
natural environment, without the need to isolate and cultivate each of the
species that make up the community, thus avoiding errors introduced by
traditional technologies. In addition, speed, specificity and reliability, one of
the advantages of metagenomics with respect to the sequencing of sequences
16s and 18s, is that it allows the identification of viruses. It also allows the
identification of parasites.
Objectives
Prove the usefulness of new technologies based on metagenomics, such as the
XGN-MBI assay to realize gut microbiota studies.
Material and methods
A study carried out in the Xenogene Laboratories about an anonymous patient,
from whom previously informed consent has been obtained to publish his data
in this article, has been utilized to demonstrate the usefulness of the XGN-MBI
assay.
From a stool sample, collected on a swab in the Cary Blair transport medium,
an extraction of nucleic acids and a massive sequencing was made. No crops or
PCRs are carried out to avoid introducing artifacts into the results.
The sequencing results in a Fastq file that is analyzed with Ubioma software
(owned by Xenogene laboratories), which is compared with various
international databases and whose results are visualized with the Krona
program and interpreted by an expert.
Figure 1: Relationship and percentages of the main Phylums of bacteria in  the total 
microbiota of the patient studied.
Figure 2: Observed distribution of bacteria by genus within the Phylum Bacterioidetes.
Figure 3: : Observed distribution of bacteria 
by species within the Phylum Bacterioidetes.
Figure 4 & 5: Observed distribution of bacteria by genus 
and species within the Phylum Firmicutes.
Figure 8 & 9: distribution of bacteria by Genus and 
species within the Phylum Firmicutes.
Figure 6 &  7: Observed distribution of bacteria 
by genus and species within the Phylum
Proteobacteria.
